Sleep Apnea Study

Spokane WA

Description

The SHARP* Study is investigating an approved study medication for people who have excessive daytime sleepiness associated with obstructive sleep apnea (OSA). OSA is a condition in which your breathing stops while you are asleep, and you have to wake up to continue breathing. The SHARP Study will explore whether the study medication improves your cognition, which can include your memory, attention, and concentration. You or someone you care for may be able to take part if you/they: - are 18-65 years of age - have been diagnosed with sleep apnea, have difficulties staying awake during the day, and have problems with memory or attention - normally sleep for more than 6 hours at night. Want to know more? If you are interested in learning more about the SHARP Study, please contact: Sleep and Performance Research Center Washington State University (509) 358-7751 *Solriamfetol's effect on cognitive Health in Apnea participants during a Randomized Placebo-controlled study